01410nam 2200397 450 991070748660332120160811084109.0(CKB)5470000002464659(OCoLC)956501056(OCoLC)995470000002464659(EXLCZ)99547000000246465920160811d2006 ua 0engurmn|||||||||rdacontentrdamediardacarrierFDA's monitoring of postmarketing study commitments[Washington, D.C.] :Department of Health and Human Services, Office of Inspector General,2006.1 online resource (iv, 38 pages) illustrationsTitle from title screen (viewed Aug 9, 2016)."June 2006.""OEI-01-04-00390."Includes bibliographical references (pages 23-28).Food and Drug Administration's monitoring of postmarketing study commitmentsFDA's monitoring of postmarketing study commitmentsDrugsUnited StatesTestingClinical trialsGovernment policyUnited StatesDrugsTesting.Clinical trialsGovernment policyGPOGPOBOOK9910707486603321FDA's monitoring of postmarketing study commitments3304907UNINA